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Monoclonal antibody B2, a marker of neuroendocrine sympathoadrenal precursors, recognizes the Luke (LKE) antigen
Laura Cooling and Debbie Hwang
BACKGROUND: Blood group antigens are physiologically important differentiation markers in embryogenesis and development. Monoclonal antibody (MoAb) B2 recognizes a transient antigen expressed on late sympathoadrenal neuroendocrine precursors and early sympathetic neuroblasts. It has been suggested that MoAb B2 may recognize a globo-series glycosphingolipid (GSL) related to the P blood group family. STUDY DESIGN AND METHODS: MoAb B2 and two anti-LKE MoAbs, MC813-70 and RM1, were screened against a panel of GSL standards and isolated red blood cell (RBC) GSLs by high-performance thin layer chromatography (HPTLC) immunostaining. The ability of all three MoAbs to bind intact RBCs and two LKE + renal cell carcinoma cell lines (A498, ACHN) were examined by flow cytometry and hemagglutination. RESULTS: MoAbs B2, MC813-70, and RM1 all specifically recognized monosialogalactosylgloboside (MSGG) on HPTLC immunostaining. Only MoAb MC813-70 bound intact RBC by flow cytometry and hemagglutination. Differential staining was observed between the three antibodies and two renal cell carcinoma cell lines. CONCLUSION: MoAb B2 recognizes MSGG or LKE antigen, suggesting that LKE may play a role in neuroendocrine differentiation from neural crest cells. Although MoAb B2 is not suitable for RBC phenotyping, it may be a useful immunologic reagent for the identification of human embryonic stem cells and renal cell and embryonic carcinoma.
lycosphingolipids (GSLs) play a major role in embryogenesis and cellular differentiation, facilitating cell-cell recognition, adhesion, signal transduction, and apoptosis networks. 1, 2 In Drosophila , arthro-family GSLs are integral in oogenesis, preimplantation development, epidermal growth factor, and Notch receptor signaling. 3 Likewise, globo-family GSLs (Table 1) on embryonic stem cells and preimplantation embryos are implicated in cell-cell recognition, adhesion, and the induction of specific transcription factors. [4] [5] [6] In mice, the absence of globoside (Gb 4 ) and long-chain globo-GSLs is lethal. 7, 8 Shifts in GSL glycotype often parallel cellular differentiation, [9] [10] [11] resulting in unique, tissue-and species-specific profiles. [11] [12] [13] In humans and other vertebrates, globo-GSLs, such as the P k (Gb 3 ) and P (Gb 4 , globoside) antigens, are commonly expressed by tissues of mesodermal origin. 12 Globo-GSLs are implicated in neural differentiation. 14 In rodents, Gb 4 or P antigen is a marker of sympathetic adrenergic neurons, which synthesize and secrete catecholamines (epinephrine, norepinephrine). 15 In in vitro models, sympathetic neural differentiation is associated G with the synthesis of additional, distinct globo-GSLs that support neural process formation and subsequent growth cone extension.
14 Finally, the globo-ganglioside monosialogalactosylgloboside (MSGG) or LKE antigen has been identified on afferent sensory neurons and sensory ganglia of the spinal cord dorsal horn and brain stem, respectively. [16] [17] [18] Adrenal chromaffin cells are also rich in globoGSLs. 14, 19 Like sympathetic neurons, adrenal chromaffin cells arise from migrating neural crest cells and synthesize catecholamines. Studies have shown that both sympathetic neurons and adrenal chromaffin cells are products of a bipotential neuroendocrine progenitor cell. [20] [21] [22] The latter differentiates rather late in development into either chromaffin cells or sympathetic neurons as a result of local environmental factors. 21, 22 Monoclonal antibody (MoAb) B2 is a transient marker on late neuroendocrine precursors and early committed neuroblasts. Although the epitope for MoAb B2 is unknown, it has been suggested that B2 may recognize a globo-series GSL. To test the latter, we screened MoAb B2 against a panel of GSL standards and isolated red blood cell (RBC) GSLs. We also tested MoAb B2 as a possible serologic agent for RBC phenotyping.
MATERIALS AND METHODS
Cells
ACHN and A498 (ATCC HTB44) cells, two renal carcinoma cell (RCC) lines, were purchased from the American Tissue Type Collection (Manassas, VA). Cells were maintained in RPMI 1640 supplemented with 10 percent fetal calf serum, 2 mmol per L L -glutamine, 1 mmol per L sodium pyruvate, 1 mmol per L nonessential amino acids, and gentamycin (50 m g/mL). Human RBCs from anonymous volunteer blood donors were obtained from the University of Michigan blood bank and typed for ABO, Lewis, and P 1 antigens per the manufacturer's instructions (Gamma Biologics, Houston, TX). All tissue procurement was in accordance with the institutional investigation review committee.
Immunologic reagents
MoAbs B2 (B2/B1, > 50 m g/mL), 22 MC813-70 (anti-MSGG/ LKE, 84 m g/mL), 23 MC631 (anti-Gb 4 , Gb 5 , > 50 m g/mL), 23, 24 MC480 (anti-Le X , > 50 m g/mL), 25 and FEA5 (anti-iI, > 50 m g/mL) 26 were purchased as hybridoma supernatants from the Developmental Studies Hybridoma Bank 
maintained by the Department of Biology at the University of Iowa (Iowa City, IA), under Contract N01-HD-2-3144. MoAb RM1 (anti-MSGG, >50 mg/mL) was a gift of A. Ito (Tohoku University School of Medicine, Sendai, Japan). 27 
LKE phenotyping
RBC units were serologically typed for LKE antigen with MoAb MC813-70 as described with modification. 28, 29 Briefly, washed RBC were digested with ficin as described by Judd. 30 For direct agglutination, one drop of ficintreated RBCs (3% in normal saline), two drops of MoAb MC31-70 supernatant, and one drop of 22 percent bovine serum albumin (BSA, Ortho, Raritan, NJ) were incubated for 2 hours at 4∞C. Samples showing macroscopic agglutination (≥1-4+) after immediate-spin centrifugation (30 sec) were considered LKE-strong positive (LKE-S). Samples that were negative at immediate-spin centrifugation were retested by the indirect antiglobulin test with MCT anti-mouse IgG gel columns (gift of H. Mylaski, MCT, Pompano, FL). For the latter, 50 mL of RBCs (0.8% suspension in MCT diluent) and 25 mL of MC813-70 were incubated for 15 minutes at 37∞C, followed by 10 minutes of centrifugation. Agglutination was scored per manufacturer's instructions. Cells showing greater than 1+ agglutination by gel were typed as LKE-weak (LKE-W). Samples weak or negative (0-1+) by gel were typed as LKE-negative (LKE-N). All LKE-W and LKE-N samples were typed twice. Globo-null RBCs (p RBC, gift from J. Judd, University of Michigan) were included as a negative control. After incubation (30 min, 4∞C), cells were washed thrice and resuspended in 500 mL of PBS-1 percent paraformaldehyde. For RBCs, washed, ficin-treated RBCs (50 mL, 3% suspension) were incubated with primary and secondary antibodies as described above. 28 Working dilutions for anti-MSGG MoAbs were 1:100 (MC813-70) and 1:10 (B2, RM1).
After fixation, cells were analyzed by one-color flow cytometry (FACScan, Becton Dickinson, Franklin Lakes, NJ) with computer software (Cell-Quest, Becton Dickinson). Cells were gated on forward and orthogonal scatter, and the percentage of FITC-positive cells was determined. All samples were stained in duplicate and recorded as the mean percentage of positive cells and mean channel fluorescence intensity.
GSL isolation
The total neutral and ganglioside fraction from lymphocytes, neutrophils, monoblasts, kidney, and brain were isolated as described previously. 11, 12 Gangliosides and neutral GSLs from LKE-typed RBC were isolated by a modified procedure of Ledeen and Yu. 31, 32 Briefly, 30 mL of LKE-typed, washed RBCs were sequentially extracted with 300 mL of chloroform-methanol (C-M) 1:1 and 1:2 (vol/ vol). After filtration, both lipid extracts were pooled, dried in vacuo, and then resuspended in 0.5 mol per L methanolic sodium hydroxide. After incubation at 37∞C for 5 hours to saponify the bulk of alkali-labile phospholipids, 33 samples were dried and dialyzed against distilled water (MW cutoff, 3000; Spectra-Por, Houston, TX; 4∞C) to desalt samples. After being dried, samples were resuspended in 100 mL C-M-water (30:60:8, vol/vol/vol) and applied to a DEAE-A25 Sephadex column (10 mL bed volume [BV], Sigma Chemical Co.). The column was washed with 200 mL of C-M-water 30:60:8 (vol/vol/vol) to remove neutral lipids, including neutral GSLs. The column was then stripped with 150 mL of C-M-0.8 mol per L sodium acetate. The acidic lipid fraction was saponified (0.1 mol/L NaOH, 2 hr, 37∞C) and dialyzed (MW cutoff 3000, SpectraPor) as before. After being dried, samples were resuspended in 35 mL of C-M 85:15 (vol/vol, 10 mL BV), applied to a silica column (10 mL BV, 40 mm; J.T. Baker, Phillipsburg, NJ), and washed with an additional 170 mL of C-M 85:15. Gangliosides were eluted with 130 mL of C-M 1:2 (vol/vol). Samples were dried and resuspended C-M 1:1 (10 mg/mL) for use.
High-performance thin-layer chromatography
High-performance thin-layer chromatography (HPTLC) was performed as described. 34 Total tissue ganglioside or neutral fraction (50 mg/lane) and GSL controls (3-5 mg/ lane) were applied to aluminum-backed HPTLC plates (E. Merck, Darmstadt, Germany), developed in C-M-0.2 percent aqueous CaCl 2 (55:45:10, vol/vol/vol). After being air-dried, GSLs were visualized chemically with diphenylamine reagent or stained by MoAbs. Individual GSLs were identified based on their relative mobility (R f ) to standards and immunoreactivity with MoAbs. GSL standards were purchased from Sigma Chemical Co. or isolated previously in our laboratory. 11, 12 Staining intensity was determined by scanning densitometry of digitally scanned images (Quantiscan, Biosoft, Ferguson, MO).
For immunostaining, HPTLC plates were dipped in poly-(iso-butyl)methacrylate (PIBM) (0.2% in hexane) for 1 minute. Plates were dried and then blocked with Tris buffer (50 mmol/L Tris-HCl, 150 mmol/L NaCl, 0.1% azide, 1% BSA; pH 7.8) for 1 hour. Plates were subsequently overlayed with primary antibody for 1 hour, washed with PBS, followed by biotinylated anti-mouse immunoglobulin and streptavidin-linked alkaline phosphatase as described. 11, 12 Working dilutions for MoAbs were 1:10 (MC813-70), 1:5 (MC631), and neat (B2, RM1). Antibody binding was detected with alkaline phosphatase in 100 mmol/L Tris (pH 9.5) for 5 minutes.
For neuraminidase digestion in situ, RBC gangliosides were separated by HPTLC as before. PIBM-fixed HPTLC plates were blocked with PBS-1 percent BSA for 15 minutes and then overlayed with Clostridium perfringens neuraminidase (type V, EC 3.2.1.18; Sigma Chemical Co., 20 mU/mL in PBS-1 percent BSA) for 2 hours at 37∞C. After digestion, plates were washed with PBS and then subjected to HPTLC immunostaining with either MoAb MC631 or MoAb FE-A5 as a control. 32 
Statistical analysis
Differences in HPTLC immunostaining results were compared by the t test. Graphic and statistical analyses were performed with computer software (KalidaGraph, Reading, PA).
RESULTS
B2 specifically recognizes MSGG or LKE antigen
It has been suggested that MoAb B2 recognizes a developmentally regulated, globo-GSL during embryonic adrenal differentiation. To test the latter, we screened B2 against a panel of GSL standards and total tissue GSLs. As shown in Table 1 and Fig. 1A , MoAb B2 specifically recognized MSGG or LKE antigen. The latter is a sialylated GSL or ganglioside that shows restricted tissue expression. 13, 32 Although MoAb B2 recognized MSGG, B2 did not cross-react with any globo-precursor (Gb 3 , Gb 4 , Gb 5 ), suggesting that B2 binding requires the presence of a terminal sialic acid. In addition, MoAb B2 did not cross-react with any ganglio-series GSLs, including GD1a. Like MSGG, the latter possesses a terminal NeuAca2-3Galb1-3GalNAcb1-R motif (Table 1) . Two known anti-MSGG/LKE MoAbs, MC813-70 and RM1, 23, 27 were tested in parallel with similar results. Overall, these results suggest that MoAb B2 requires both a terminal sialic acid and a globo-oligosaccharide core for recognition.
MoAb B2 recognizes a LKE-active ganglioside in RBC
MSGG is reportedly the LKE antigen on human RBCs. 28, 29 We therefore tested MoAb B2 against the total ganglioside fraction of LKE-S RBCs (Fig. 1D, Lane 2) . MoAb B2 recognized a trace ganglioside in LKE-S RBC with the same mobility as the MSGG standard (Fig. 1D, Lane 1, R f 0.30) . A RBC ganglioside with similar mobility was also observed after staining with MoAbs MC813-70 (Fig. 1E ) and RM1 ( Fig. 1F) . No B2 binding was observed to any GSL in the neutral fraction of RBC (Fig. 1A , Lane 1). To confirm that the B2+ band in RBC was MSGG-LKE, RBC gangliosides were first digested with neuraminidase in situ to remove the terminal sialic acid (Table 1 ) and then stained with MoAb MC631, an anti-Gb 5 /Gb 4 MoAb. 23, 32 As shown, a MC631+ band was detected (Fig. 1G) with the same mobility as MSGG and MoAb B2.
B2 staining is dependent on LKE-phenotype
To determine whether B2 staining to RBC gangliosides was dependent on LKE phenotype, MoAb B2 was tested against a panel of RBC gangliosides isolated from LKE-N (n = 2), LKE-W (n = 4), and LKE-S donors (n = 9). B2 binding was compared by scanning densitometry of HPTLC plates (Fig. 2) . MoAbs MC813-70 and RM1 were included as controls, as before.
In the MC813-70 control ( Fig. 2A) , there was a clear dose-response relationship between staining intensity and LKE phenotype, which was significant (p < 0.001, t test). MoAbs B2 and RM1 strongly stained LKE-S samples; however, little or no staining was observed in LKE-W and LKE-N samples. The inability of either MoAb B2 or RM1 to significantly bind LKE-W and LKE-N samples suggests that these antibodies may require a minimum antigen concentration and density to support antibody binding.
MSGG and B2 ganglioside have restricted tissue expression
MSGG-LKE expression is relatively restricted on human tissues. To verify that the B2 antigen shares the same tissue distribution and restriction as the LKE-MSGG antigen, MoAbs B2 and MC813-70 were screened against the ganglioside fractions from RBC, lymphocytes, neutrophils, monocytes, kidney, and brain. Consistent with the known distribution of MSGG, 5, 23, 32 MC813-70+ and B2+ gangliosides were observed in RBCs and kidney. No bands were observed in any other tissues tested.
MoAb B2 does not hemagglutinate human RBC
The ability of MoAbs B2, RM1, and MC813-70 to agglutinate RBCs was tested against either washed or ficinmodified LKE-S RBC using standard conditions established for MoAb MC813-70. 28, 29 No MoAb tested was capable of agglutinating washed RBCs. As reported, 29 MoAb MC813-70 strongly agglutinated ficin-modified LKE-S RBC. In contrast, neither MoAb B2 nor MoAb RM1 agglutinated ficin-treated RBCs, even after prolonged 4∞C incubation (up to 4 hr), increasing the antibody-cell ratio and filter concentrating the antibody 50-fold. Contrary to expectations, MoAb B2 is not a viable serologic reagent for LKE phenotyping.
Differential reactivity of anti-MSGG-LKE MoAbs by flow cytometry
The reactivities of MoAbs B2, RM1, and MC813-70 were also compared by flow cytometry (Fig. 3) . All three MoAbs were tested against ficin-treated LKE-S RBCs and two, MSGG+ RCC lines, A498 and ACHN. MSGG-LKE is strongly expressed in some RCCs, where it is hypothesized to play a role in tumor growth and metastasis. 35, 36 As previously reported, 28, 29 
DISCUSSION
MSGG or LKE antigen is a high-incidence antigen (98%-99% of donors) on human RBCs. 28, 29 Because it is a high-incidence RBC antigen, very few examples of human anti-LKE are described in the literature. [38] [39] [40] Like anti-P k and P antibodies, examples of human anti-LKE are typically of IgM isotype, showing enhanced reactivity at 4∞C and after protease digestion. 38 Although human anti-LKE is not readily available, MoAb MC813-70, a murine MoAb Staining was quantitated by scanning densitometry (area, mean ± ± ± ± SD).
with anti-MSGG specificity, 23 has been validated as an anti-LKE serologic reagent. 28, 29, 40 MoAb MC813-70 was shown to have LKE specificity, failing to hemagglutinate p, P k , and LKE-N RBC controls. 29 Unlike examples of human anti-LKE, MoAb MC813-70 strictly requires prior enzyme modification of RBC for binding. This difference may reflect differences in antibody class between MoAb MC813-70 (IgG4) and human anti-LKE (IgM). MoAb MC813-70 also differs subtly from human anti-LKE in large population studies. Examples of human anti-LKE suggest an association between ABO and weak LKE expression whereas no linkage disequilibrium is observed with MoAb MC813-70. 28, 29, 38 In this study, we evaluated two IgM, anti-MSGG MoAbs B2 and RM1. RM1, raised against MSGG isolated from metastatic RCC, has strict specificity for MSGG. 27 Likewise, we have shown that B2, an antibody raised against embryonic adrenal cells, [20] [21] [22] also has anti-MSGG activity. Both antibodies recognized MSGG present in the RBC ganglioside fraction by HPTLC immunostaining; however, neither antibody bound intact RBC membranes by either flow cytometry or direct agglutination assays. In contrast, both antibodies stained RCCs, suggesting that these antibodies may require a higher antigen density on cell membranes to support antibody binding. Unlike human RBCs, in which LKE is a trace ganglioside (<1%-2% total), MSGG is a major RCC ganglioside, constituting up to 50 percent total ganglioside and 90 percent of the GSL present in lipid-rafts. 35, 36 The identification of the B2 antigen as MSGG-LKE suggests a possible role for LKE in neural crest differentiation. It is well established that neurons of the sympathetic nervous system and adrenal chromaffin cells share a common embryonic heritage via the caudal neural crest. [20] [21] [22] A transient marker on bipotential embryonic adrenal cells, LKE or B2 antigen signals early neuroblast commitment along sympathetic neural development. 21 In the spinal cord, which also arises from the caudal neural crest, LKE, and its precursor Gb 5 (Table 1) , specifically identify subsets of myelinated afferent sensory neurons responsible for transmitting proprioception and touch. [16] [17] [18] After synapsing in the spinal cord dorsal horn, these LKE+ neurons synapse with their corresponding sensory ganglia in the cerebellum.
Like their dorsal horn counterparts, these afferent sensory ganglia cells are also LKE-positive. 16, 17 In summary, we have identified the B2 antigen as the globo-ganglioside, MSGG, or LKE antigen. Our findings suggest a potential role for MSGG in neuroendocrine differentiation, marking immature sympathetic neuroblasts and bipotential embryonic adrenal chromaffin cells. Unfortunately, MoAb B2 is not useful as a serologic reagent for RBC phenotyping. MoAb B2 may, however, be a useful reagent for embryonic stem cells, 4, 5 embryonic carcinoma cells, and RCCs, 6, 13, 35, 36 which strongly express MSGG or LKE antigen.
